Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Connetics reports positive phase II clinical data for treatment of scleroderma

June 15, 2000

Highly potent and selective COX-2 inhibitors emerge from Glaxo Wellcome R&D

June 14, 2000

Japanese investigators isolate new type of antiinflammatory peptide

June 14, 2000

Isis and Elan joint venture moves ISIS-104838 towards clinical development

June 14, 2000

Japanese researchers discover new antiinflammatory substance

June 13, 2000

Cytokine production inhibitors described in patent literature by Novartis

June 13, 2000

CLX-1100: a novel antiinflammatory agent produced by a Himalayan plant

June 13, 2000

Cytokine production inhibitors developed by SB for inflammatory disorders

June 9, 2000

Orally active and selective COX-2 inhibitors described by Abbott

June 9, 2000

Preliminary pharmacological profile of NMI-377 presented at ASBMB/ASPET 2000

June 9, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...